Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.

By Amir Safavi | March 5, 2023 |

Link: https://doi.org/10.1210/clinem/dgab882 Authors: Wang, Bowen; Wang, Zehai; Poundarik, Atharva A; Zaki, Mohammed J; Bockman, Richard S; Glicksberg, Benjamin S; Nadkarni, Girish N; Vashishth, Deepak Abstract: Fracture risk is underestimated in people with type 2 diabetes (T2D). To investigate the longitudinal relationship of glycated hemoglobin (HbA1c) and common medications on fracture risk in people with T2D.…

Read More

Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial.

By Amir Safavi | January 11, 2022 |

Link: https://doi.org/10.1159/000519920 Authors: Lam, David; Nadkarni, Girish N; Mosoyan, Gohar; Neal, Bruce; Mahaffey, Kenneth W; Rosenthal, Norman; Hansen, Michael K; Heerspink, Hiddo J L; Fleming, Fergus; Coca, Steven G Abstract: KidneyIntelX is a composite risk score, incorporating biomarkers and clinical variables for predicting progression of diabetic kidney disease (DKD). The utility of this score in…

Read More